{"id":"https://openalex.org/W2567501637","doi":"https://doi.org/10.1182/blood.v126.23.1745.1745","title":"Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program","display_name":"Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2567501637","doi":"https://doi.org/10.1182/blood.v126.23.1745.1745","mag":"2567501637"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.1745.1745","doi":"https://doi.org/10.1182/blood.v126.23.1745.1745","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1745.1745","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071144394","display_name":"Lotta Hansson","orcid":"https://orcid.org/0000-0001-6614-5737","observed_orcids":["https://orcid.org/0000-0001-6614-5737"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Lotta Hansson","raw_affiliation_strings":["Department of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003841375","display_name":"Maria Winqvist","orcid":"https://orcid.org/0000-0003-0905-2424","observed_orcids":["https://orcid.org/0000-0003-0905-2424"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Maria Winqvist","raw_affiliation_strings":["Department of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089576328","display_name":"Anna Asklid","orcid":"https://orcid.org/0009-0009-3681-9345","observed_orcids":["https://orcid.org/0009-0009-3681-9345"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Anna Asklid","raw_affiliation_strings":["Department of Oncology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109946088","display_name":"P-O Andersson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P-O Andersson","raw_affiliation_strings":["Department of Hematology, Bor\u00e5s Hospital, Bor\u00e5s, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Bor\u00e5s Hospital, Bor\u00e5s, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023390126","display_name":"Karin Karlsson","orcid":"https://orcid.org/0000-0001-5029-1086","observed_orcids":["https://orcid.org/0000-0001-5029-1086"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Karin Karlsson","raw_affiliation_strings":["Department of Hematology, Lund University Hospital, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Lund University Hospital, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089373395","display_name":"Claes Karlsson","orcid":"https://orcid.org/0009-0003-8971-2249","observed_orcids":["https://orcid.org/0009-0003-8971-2249"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Claes Karlsson","raw_affiliation_strings":["Department of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004823958","display_name":"Birgitta Lauri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089554","display_name":"Sunderby sjukhus","ror":"https://ror.org/0084bse20","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210089554"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Birgitta Lauri","raw_affiliation_strings":["Department of Hematology, Sunderbyn Hospital, Sunderbyn-Lule\u00e5, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Sunderbyn Hospital, Sunderbyn-Lule\u00e5, Sweden","institution_ids":["https://openalex.org/I4210089554"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043417410","display_name":"Jeanette Lundin","orcid":"https://orcid.org/0000-0002-4473-5450","observed_orcids":["https://orcid.org/0000-0002-4473-5450"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Jeanette Lundin","raw_affiliation_strings":["Department of Hematology, Karolinska University Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Karolinska University Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025276852","display_name":"Mattias Mattsson","orcid":"https://orcid.org/0000-0002-9510-8801","observed_orcids":["https://orcid.org/0000-0002-9510-8801"]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Mattias Mattsson","raw_affiliation_strings":["Department of Hematology, Uppsala University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Uppsala University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023386496","display_name":"Stefan Norin","orcid":"https://orcid.org/0000-0002-7056-9900","observed_orcids":["https://orcid.org/0000-0002-7056-9900"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Stefan Norin","raw_affiliation_strings":["Department of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046927330","display_name":"Anna Bergendahl Sandstedt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151885","display_name":"Link\u00f6ping University Hospital","ror":"https://ror.org/05h1aye87","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210151885"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Anna Sandstedt","raw_affiliation_strings":["Department of Hematology, Link\u00f6ping University Hospital, Link\u00f6ping, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Link\u00f6ping University Hospital, Link\u00f6ping, Sweden","institution_ids":["https://openalex.org/I4210151885"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049924304","display_name":"Anders \u00d6sterborg","orcid":"https://orcid.org/0000-0001-6489-4865","observed_orcids":["https://orcid.org/0000-0001-6489-4865"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Anders \u00d6sterborg","raw_affiliation_strings":["Department of Hematology, Karolinska University Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Karolinska University Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5003841375","https://openalex.org/A5004823958","https://openalex.org/A5023390126","https://openalex.org/A5025276852","https://openalex.org/A5043417410","https://openalex.org/A5046927330","https://openalex.org/A5071144394","https://openalex.org/A5089576328"],"corresponding_institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I1342360035","https://openalex.org/I187531555","https://openalex.org/I28166907","https://openalex.org/I4210089554","https://openalex.org/I4210151885"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.3241,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.80654145,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"126","issue":"23","first_page":"1745","last_page":"1745"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9639999866485596},{"id":"https://openalex.org/keywords/relapsed-refractory-chronic-lymphocytic-leukemia","display_name":"relapsed/refractory chronic lymphocytic leukemia","score":0.9520000219345093},{"id":"https://openalex.org/keywords/small-lymphocytic-lymphoma","display_name":"small lymphocytic lymphoma","score":0.906000018119812},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.7549999952316284},{"id":"https://openalex.org/keywords/compassionate-use-program","display_name":"compassionate use program","score":0.9350000023841858},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.8740000128746033},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8510000109672546},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.718999981880188},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.7599999904632568},{"id":"https://openalex.org/keywords/persistent-lymphocytosis","display_name":"persistent lymphocytosis","score":0.765999972820282},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5450000166893005},{"id":"https://openalex.org/keywords/swedish-patients","display_name":"Swedish patients","score":0.48500001430511475},{"id":"https://openalex.org/keywords/richter-transformation","display_name":"Richter transformation","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9748021364212036},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8202961683273315},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6605892181396484},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6487202048301697},{"id":"https://openalex.org/C2780126324","wikidata":"https://www.wikidata.org/wiki/Q612345","display_name":"Lymphocytosis","level":2,"score":0.5843441486358643},{"id":"https://openalex.org/C2779260929","wikidata":"https://www.wikidata.org/wiki/Q5908266","display_name":"Idelalisib","level":5,"score":0.5730574131011963},{"id":"https://openalex.org/C2779788671","wikidata":"https://www.wikidata.org/wiki/Q998803","display_name":"Tumor lysis syndrome","level":3,"score":0.5134235620498657},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.464886873960495},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.44898703694343567},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4238005578517914},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4151572585105896},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35598477721214294},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.35191333293914795},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.17117196321487427},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.13560345768928528},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.07044810056686401},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.1745.1745","doi":"https://doi.org/10.1182/blood.v126.23.1745.1745","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1745.1745","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3193140429","https://openalex.org/W2399623634","https://openalex.org/W2980405244","https://openalex.org/W2951445008","https://openalex.org/W2580953357","https://openalex.org/W74759347","https://openalex.org/W2913229295","https://openalex.org/W2519917066","https://openalex.org/W4283321015","https://openalex.org/W2775394648"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Patients":[2,106,188],"with":[3,12,39,43,92,107,204,213,251,262,265,319,326,427,638,664],"relapsed/refractory":[4],"(R/R)":[5],"chronic":[6],"lymphocytic":[7,125],"leukemia":[8],"(CLL)":[9],"and":[10,70,182,230,255,273,299,334,368,411,450,514,637,663,681],"those":[11,42,71],"del":[13,44,141,302,668],"17p":[14,45,142,303,669],"CLL":[15,40,94,108,122,137,156,547,611],"have":[16,577],"a":[17,23,59,100,118,152,166,175,183,437,530,553,614,627,639,659,665],"poor":[18,609],"prognosis.":[19],"Ibrutinib":[20,536],"(ImbruvicaTM)":[21],"is":[22,57,600],"first-in-class":[24],"Bruton\u00b4s":[25],"tyrosine":[26],"kinase":[27],"(BTK)":[28],"inhibitor":[29,169],"that":[30,625,653],"has":[31,676],"recently":[32],"been":[33,362,454,679],"approved":[34],"for":[35,111,155,161,364,461,543],"previously":[36,645],"treated":[37],"patients":[38,64,91,242,260,298,318,359,377,413,458,464,520,528,542,576,612,655,683],"or":[41,123,132,139,170,205,214,248,287,290,323,341,432,472,501,571,595],"after":[46,131,552],"having":[47,667],"demonstrated":[48],"convincing":[49],"effects":[50],"in":[51,67,74,87,99,146,296,311,371,395,479,490,506,518,525,540],"pivotal":[52,629],"clinical":[53,68,630],"studies.":[54],"However,":[55],"there":[56],"often":[58],"discrepancy":[60],"between":[61,269],"data":[62],"from":[63,613],"strictly":[65],"included":[66,268,315,370,394],"trials":[69],"later":[72],"obtained":[73],"routine":[75],"health":[76],"care.":[77],"We":[78],"report":[79],"here":[80],"the":[81,112,354,372,389,396,447,482,544,601,695],"first":[82,602],"Real-World":[83,603],"results":[84,690],"on":[85,416,605,685],"ibrutinib":[86,162,193,386,418,534,606,621,687],"97":[88],"consecutive":[89],"Swedish":[90],"poor-prognosis":[93],"who":[95,378],"received":[96,189,257,380],"their":[97],"treatment":[98,153,172,401,607],"compassionate":[101],"use":[102],"program":[103],"(CUP).":[104],"Methods:":[105],"were":[109,133,199,238,243,249,267,284,351,369,393,434,459,466,493,511,581,656],"eligible":[110],"CUP":[113],"if":[114],"they":[115,246],"a)":[116],"had":[117,129,140,151,158,174,301,336,361,379,452,529,658],"confirmed":[119],"diagnosis":[120],"of":[121,178,222,232,317,345,356,385,391,441,481,485,556,608,620,626],"small":[124],"lymphoma":[126],"(SLL)":[127],"b)":[128],"relapsed":[130],"refractory":[134],"to":[135,469,624],"conventional":[136],"therapy":[138],"/":[143,304,670],"TP53":[144,291,305,671],"disruption":[145],"any":[147,486,515],"disease":[148],"phase":[149],"c)":[150],"indication":[154],"d)":[157],"no":[159],"contraindication":[160],"such":[163],"as":[164,245,644],"receiving":[165],"strong":[167],"CYP3A":[168],"warfarin":[171],"e)":[173],"neutrophil":[176],"count":[177,185,219],"at":[179,327,381,388,403,694],"least":[180,328,365,382],"0.5x109/L":[181],"platelet":[184],"above":[186],"30x109/L.":[187],"420":[190],"mg":[191],"oral":[192],"once":[194],"daily":[195],"until":[196],"progression.":[197],"Endpoints":[198],"overall":[200,228],"response":[201,223,236],"rate":[202,212],"(ORR)":[203],"without":[206,215],"persistent":[207],"lymphocytosis,":[208],"complete":[209,217],"remission":[210],"(CR)":[211],"(CRi)":[216],"blood":[218],"recovery,":[220],"duration":[221,402],"(DOR),":[224],"progression-free":[225],"survival":[226,229],"(PFS),":[227],"safety":[231,397],"ibrutinib.":[233,258],"The":[234,277,399,579,618,673],"IWCLL":[235],"criteria":[237],"applied.":[239],"Results:":[240],"Fourenrolled":[241],"excluded":[244],"died":[247],"diagnosed":[250],"Richter":[252],"transformation":[253],"(RT)":[254],"never":[256],"Ninety-seven":[259],"(95":[261],"CLL,":[263],"2":[264,340,366],"SLL)":[266],"May":[270,274],"15,":[271],"2014":[272],"31,":[275],"2015.":[276],"median":[278,344,400,438,448,554,674],"age":[279],"was":[280,294,309,405,422,488,497,504,537,622],"69":[281],"years":[282,286],"(24%":[283],"75":[285],"older).":[288],"FISH":[289],"mutation":[292],"test":[293],"performed":[295],"82":[297],"61%":[300],"disruption.":[306,672],"Del":[307],"11q":[308],"present":[310],"17%.":[312],"Baseline":[313],"characteristics":[314],"65%":[316],"Rai":[320],"Stage":[321],"III":[322],"IV,":[324],"48%":[325],"one":[329,383,510],"lymph":[330],"node":[331],">5":[332],"cm":[333],"25%":[335,425],"performance":[337,661],"status":[338,662],"grade":[339,470,476,487,494,498,512],"3.":[342],"A":[343],"3":[346,471],"prior":[347],"therapies":[348],"(range":[349,408,444],"0-10)":[350],"reported.":[352,435],"At":[353,436],"time":[355,390,440,555],"writing,":[357],"81":[358],"(86%)":[360],"enrolled":[363],"months":[367,407,443],"preliminary":[373],"efficacy":[374,619],"analysis.":[375,398],"All":[376],"dose":[384],"(n=92)":[387],"writing":[392],"analysis":[404,604],"6.8+":[406,442],"0-12.7+":[409],"months)":[410,446],"78":[412],"(85%)":[414],"remain":[415,684],"continuous":[417,686],"therapy.":[419,688],"Investigator-assessed":[420],"ORR":[421],"80%":[423],"including":[424],"PR":[426],"lymphocytosis":[428],"(PR-L).":[429],"No":[430],"CR":[431],"CRi":[433],"follow-up":[439],"0.5-12.7+":[445],"PFS":[449,675],"DOR":[451],"not":[453,677],"reached.":[455],"Ninety-":[456],"two":[457],"evaluable":[460],"toxicity.":[462],"Twenty-five":[463],"(27%)":[465],"hospitalized":[467],"due":[468],"worse":[473],"infection.":[474],"Neutropenia":[475],"4":[477],"occurred":[478,517,524],"16%":[480],"patients.":[483],"Diarrhea":[484],"reported":[489,505,646],"17%":[491],"(4%":[492],"3,":[495],"none":[496],"4).":[499],"Arthralgia":[500],"muscle":[502],"pain":[503],"15%":[507],"(all":[508],"but":[509],"1-2)":[513],"hemorrhage":[516],"30":[519],"(33%).":[521],"Atrial":[522],"fibrillation":[523],"3%.":[526],"Three":[527],"secondary":[531,592],"tumor":[532,593],"during":[533],"treatment.":[535],"permanently":[538],"stopped":[539],"13":[541],"following":[545],"reasons:":[546],"progression":[548,582],"(n=1),":[549,568,589],"RT":[550,584],"(n=4,":[551],"7.6":[557],"months,":[558],"range":[559],"3.7-10.3),":[560],"cutaneous":[561],"adverse":[562,641],"event":[563,642],"(n=2),":[564,585],"congestive":[565,586],"heart":[566,587],"failure":[567,588],"infections":[569],"(n=3)":[570],"other":[572],"malignancy":[573],"(n=2).":[574],"Twelve":[575],"died.":[578],"reasons":[580],"(n=3),":[583,591],"infection":[590],"(n=2)":[594],"unknown":[596],"(n=1).":[597],"Conclusions:":[598],"This":[599],"prognosis":[610],"well-defined":[615],"geographical":[616],"region.":[617],"similar":[623,640],"previous":[628],"trial":[631],"(Byrd":[632,647],"et":[633,648],"al":[634],"NEJM":[635,650],"2013)":[636],"profile":[643],"al,":[649],"2014)":[651],"despite":[652],"our":[654],"older,":[657],"lower":[660],"majority":[666],"yet":[678],"reached":[680],"most":[682],"Updated":[689],"will":[691],"be":[692],"presented":[693],"meeting.":[696],"Disclosures":[697],"Hansson:":[698],"Jansse":[699],"Cilag:":[700,704,708],"Research":[701,705,709,712,715,723,726],"Funding.":[702,706,710,716,727],"Winqvist:Janssen":[703],"Asklid:Janssen":[707],"Lundin:Janssen:":[711],"Funding;":[713,724],"Novartis:":[714,725],"Mattsson:Janssen:":[717],"Consultancy.":[718],"\u00d6sterborg:Janssen,":[719],"Pharmacyclics,":[720],"Gilead:":[721],"Consultancy,":[722]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-06T00:00:00"}